Abstract:The expression of EGLN2 gene was inhibited by the enrichment of YPA1 protein in EGLN2 promoter region after the transferring of YPA1 protein from cytoplasm to nucleus. EGLN2 protein promoted the degradation of HIF1‐α by polyubiquitination of HIF1‐α protein in cytoplasm. HIF1‐α, a regulator of anabolic glycolysis, promoted the transcription of a series of glycolytic gene expression, including GLUT1, Hk2 and LDHA, through binding to the hypoxia response element (HRE) of the target gene. Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases and has remarkably high mortality rates. In recent years, altered metabolism has been shown to contribute to the maintenance of pancreatic cancer malignancies. However, the molecular mechanism underlying glucose metabolism reprogramming remains elusive. The aim of this study was to elucidate the role of Yes‐associated protein (YAP1), an important effector of the Hippo pathway, in the regulation of aerobic glycolysis in pancreatic cancer. Moreover, the contributions of YAP1 and its associated glycolytic enzymes to prognosis were assessed via The Cancer Genome Atlas (TCGA) dataset. Methods YAP1 expression was silenced by short hairpin RNA (shRNA), and its effects on glycolytic activity and mitochondrial respiration were analysed via Agilent Seahorse XF Analysers. The effects of YAP1 on hypoxia‐inducible factor‐1α (HIF‐1α) and its transcriptional activity on glycolytic genes were examined via shRNA‐mediated silencing of YAP1. The underlying mechanism by which YAP1 controls the HIF‐1α protein level was analysed by exploring the interaction between YAP1 and egg‐laying‐defective nine family (EGLN) members, which are well‐established regulators of the HIF‐1α protein level. Finally, the effects of YAP1, EGLN and glycolytic genes on prognosis were analysed via TCGA dataset. Results We found that silencing YAP1 expression inhibited anabolic glycolysis in pancreatic cancer cells. YAP1 was demonstrated to regulate the HIF‐1α protein level, transcriptional activity and the expression of HIF‐1α‐targeted glycolytic genes. In‐depth analysis demonstrated that EGLN2, a modulator of the HIF‐1α protein level, was a direct target of YAP1. Low EGLN2 expression was associated with a poor prognosis. By analysing TCGA dataset and performing immunohistochemical staining, we demonstrated that YAP1 expression was negatively correlated with EGLN2 expression at the mRNA level and protein levels. Conclusions The present study demonstrated that YAP1 positively regulates aerobic glycolysis by inhibiting EGLN2 expression, which results in an increased HIF‐1α protein level and transcriptional activity. YAP1 was positively regulated and significantly correlated with HIF‐1α‐targeted glycolytic genes, including glucose transporter type 1(GLUT1), hexokinase2 (HK2) and lactate dehydrogenase A (LDHA). Elevated YAP1 expression and concomitant downregulation of EGLN2 contributed to poor survival in patients with pancreatic cancer. Our results suggest that YAP1 may be a promising predictive marker and treatment target for human pancreatic cancer.

HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression

HIF-1 alpha/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression

HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress

OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP

A Potential Role for the Hippo Pathway Protein, Yap, in Controlling Proliferation, Cell Cycle Progression, and Autophagy in Bcpap and Ki Thyroid Papillary Carcinoma Cells

YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma

Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A‐mediated fatty acid oxidative pathway

Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis

Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy

Abstract IA21: the Hippo Pathway in Cancer

LncRNA Wires Up Hippo and Hedgehog Signaling to Reprogramme Glucose Metabolism

High Expression of Yes-activated Protein-1 in Papillary Thyroid Carcinoma Correlates With Poor Prognosis.

Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress

YAP ISGylation increases its stability and promotes its positive regulation on PPP by stimulating 6PGL transcription

LDHA Induces EMT Gene Transcription and Regulates Autophagy to Promote the Metastasis and Tumorigenesis of Papillary Thyroid Carcinoma

BRAFV600E/p-ERK/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer

Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia

HIF-1α Switches the Functionality of TGF-β Signaling Via Changing the Partners of Smads to Drive Glucose Metabolic Reprogramming in Non-Small Cell Lung Cancer.

The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis

Inhibiting YAP Expression Suppresses Pancreatic Cancer Progression by Disrupting Tumor-Stromal Interactions

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.